Free beta — full access, free until October 2026. No card, no auto-charge — paid plans are opt-in when they launch.
Company
INTERPACE BIOSCIENCES, INC. (IDXG)
Standardized SEC financial data for INTERPACE BIOSCIENCES, INC. — income statement, balance sheet, cash flow and 40+ ratios, available as a clean JSON API. CIK 0001054102 · OTC · Surgical & Medical Instruments & Apparatus.
Gross margin
62.3%
Operating margin
10.6%
Net margin
63.5%
Revenue growth (YoY)
-17.5%
Return on equity
109.9%
ROIC
7.3%
Free cash flow
$5.5M
Debt / equity
0.11×
Ratios for fiscal year 2025, standardized from SEC filings.